The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

Roughly 70,000 people were approved for coverage under the public dental insurance program, but were later deemed ineligible ...

Health P.E.I.'s CEO says while the Island has made "tremendous" gains in bringing in more health-care staff, it's still not ...

The advisory is the latest pushback on claims raised by U.S. President Donald Trump and his top political health appointees ...

Canada is poised to lose its measles elimination status after nearly three decades, and public health experts fear outbreaks ...